WO2005068464A3 - Process for preparing tadalafil and its intermediates - Google Patents

Process for preparing tadalafil and its intermediates Download PDF

Info

Publication number
WO2005068464A3
WO2005068464A3 PCT/IN2004/000389 IN2004000389W WO2005068464A3 WO 2005068464 A3 WO2005068464 A3 WO 2005068464A3 IN 2004000389 W IN2004000389 W IN 2004000389W WO 2005068464 A3 WO2005068464 A3 WO 2005068464A3
Authority
WO
WIPO (PCT)
Prior art keywords
intermediates
tadalafil
preparing tadalafil
preparing
processes
Prior art date
Application number
PCT/IN2004/000389
Other languages
French (fr)
Other versions
WO2005068464A2 (en
Inventor
Braj Bhushan Lohray
Vidya Bhushan Lohray
Sunil Indulal Patel
Original Assignee
Cadila Healthcare Ltd
Braj Bhushan Lohray
Vidya Bhushan Lohray
Sunil Indulal Patel
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cadila Healthcare Ltd, Braj Bhushan Lohray, Vidya Bhushan Lohray, Sunil Indulal Patel filed Critical Cadila Healthcare Ltd
Publication of WO2005068464A2 publication Critical patent/WO2005068464A2/en
Publication of WO2005068464A3 publication Critical patent/WO2005068464A3/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/14—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Peptides Or Proteins (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

Processes for preparing Tadalafil and its intermediates are claimed, as is a novel form of Tadalafil.
PCT/IN2004/000389 2003-12-15 2004-12-14 Process for preparing tadalafil and its intermediates WO2005068464A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN1270/MUM/2003 2003-12-15
IN1270MU2003 2003-12-15

Publications (2)

Publication Number Publication Date
WO2005068464A2 WO2005068464A2 (en) 2005-07-28
WO2005068464A3 true WO2005068464A3 (en) 2005-12-08

Family

ID=34779411

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IN2004/000389 WO2005068464A2 (en) 2003-12-15 2004-12-14 Process for preparing tadalafil and its intermediates

Country Status (1)

Country Link
WO (1) WO2005068464A2 (en)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006049986A1 (en) * 2004-10-28 2006-05-11 Dr. Reddy's Laboratories Ltd. Polymorphic forms of tadalafil
MX2007009707A (en) * 2005-02-25 2007-09-12 Teva Pharma Process of synthesizing tadalafil.
US7417044B2 (en) 2005-02-25 2008-08-26 Teva Pharmaceutical Industries Ltd. Tadalafil having a large particle size and a process for preparation thereof
WO2007052283A1 (en) * 2005-10-31 2007-05-10 Alembic Limited An improved process for preparing tadalafil and its intermediate
US8445698B2 (en) 2007-06-29 2013-05-21 Ranbaxy Laboratories Limited Process for the preparation of an intermediate of tadalafil
EP2107059A1 (en) 2008-03-31 2009-10-07 LEK Pharmaceuticals D.D. Conversion of tryptophan into ß-carboline derivatives
WO2009144734A1 (en) * 2008-05-28 2009-12-03 Hetero Research Foundation Process for preparation of tadalafil
PL385356A1 (en) 2008-06-03 2009-12-07 Zakłady Farmaceutyczne POLPHARMA Spółka Akcyjna Method of tadalaphil production
WO2012107549A1 (en) 2011-02-10 2012-08-16 Interquim, S.A. PROCESS FOR OBTAINING COMPOUNDS DERIVED FROM TETRAHYDRO-ß-CARBOLINE
CN105106216A (en) * 2015-09-11 2015-12-02 青岛蓝盛洋医药生物科技有限责任公司 Drug tadalafil composition capsules for treating impotence of males
CN105272981A (en) * 2015-11-19 2016-01-27 中国药科大学 New Tadalafil crystal form
CN105384740A (en) * 2015-12-18 2016-03-09 海南通用康力制药有限公司 Tadanafil preparation intermediate high purity crystal and preparation method thereof
CN105481860B (en) * 2015-12-31 2018-03-02 山西普德药业有限公司 A kind of process for refining of Tadalafei I type crystal
CN107759592A (en) * 2017-11-01 2018-03-06 吉林医药学院 The preparation of tadalafil intermediate
RU2692764C1 (en) * 2019-04-26 2019-06-27 Общество с ограниченной ответственностью "Балтфарма" Method of producing tadalafil
CN115184531B (en) * 2021-04-07 2024-06-11 浙江康恩贝制药股份有限公司 Method for simultaneously measuring content of 3 impurities in tadalafil

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995019978A1 (en) * 1994-01-21 1995-07-27 Laboratoires Glaxo Wellcome S.A. Tetracyclic derivatives, process of preparation and use
WO1996038131A1 (en) * 1995-06-02 1996-12-05 Glaxo Group Limited Method of producing a solid dispersion of a poorly water soluble drug
US6140329A (en) * 1995-07-14 2000-10-31 Icos Corporation Use of cGMP-phosphodiesterase inhibitors in methods and compositions to treat impotence

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995019978A1 (en) * 1994-01-21 1995-07-27 Laboratoires Glaxo Wellcome S.A. Tetracyclic derivatives, process of preparation and use
WO1996038131A1 (en) * 1995-06-02 1996-12-05 Glaxo Group Limited Method of producing a solid dispersion of a poorly water soluble drug
US6140329A (en) * 1995-07-14 2000-10-31 Icos Corporation Use of cGMP-phosphodiesterase inhibitors in methods and compositions to treat impotence

Also Published As

Publication number Publication date
WO2005068464A2 (en) 2005-07-28

Similar Documents

Publication Publication Date Title
WO2005068464A3 (en) Process for preparing tadalafil and its intermediates
WO2007001385A3 (en) Process for preparing 4,5-dihydro-pyrazolo [3,4-c] pyrid-2-ones
WO2006018220A8 (en) Method for the production of dihydropteridinones
MX270158B (en) Production of a fermentation product.
WO2006067456A3 (en) Process for preparing rosuvastatin
WO2003070725A3 (en) Process for preparing indolinone derivatives
WO2009157019A3 (en) Process for preparing ezetimibe using novel allyl intermediates
WO2006061215A3 (en) 2-alkyl-cycloalk(en)yl-carboxamides
WO2006052768A3 (en) Process for preparing quinoline compounds and products obtained therefrom
WO2006036949A3 (en) Preparation of n-aryl pyridones
WO2004035800A3 (en) Intermediate cefdinir salts
WO2005049561A3 (en) Processes for preparing novel methylene blue derivative
WO2004052881A3 (en) Process for preparing (s)-pantoprazole
WO2007026373A3 (en) Process for preparing rivastigmine
WO2006043175A3 (en) Process for preparing purine compounds
AU2003226138A1 (en) Process for preparing phenylorganosilicon intermediates
WO2005004606A3 (en) Pyridinylanilides
WO2002096799A3 (en) Silicon subnitride method for production and use of said subnitride
WO2004096828A3 (en) Novel method and intermediates for the preparation of 19-nor-steroid compounds
AU2003290400A1 (en) A novel synthesis of 2-azabicyclic-3-carboxylic acids, useful as important drug intermediates
WO2004018466A3 (en) A method of preparing enantiomers of indole-2,3-dione-3-oxime derivatives
WO2004011449A3 (en) Method for the production of phenylalanine derivatives
AU2003295110A1 (en) Production process of gamma-cyhalothrin
WO2005023758A3 (en) Process for the preparation of losartan potassium form i
AU2003254450A1 (en) Process for preparing of paclitaxel

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DPEN Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed from 20040101)
NENP Non-entry into the national phase

Ref country code: DE

WWW Wipo information: withdrawn in national office

Country of ref document: DE

122 Ep: pct application non-entry in european phase